Quarterly Report Q1 2018

June 6, 2018

Prometic reports its 2018 first quarter highlights and financial results

  • Q1 results support expected 2018 full year spending decrease of approximately $15M
  • Sale of excess plasma inventory xompleted in April contributing $14M to proforma cash runway of $91M
  • Clinical programs streamlined to manage costs for balance of 2018
  • Continued positive clinical activity demonstrated by PBI-4050 to catalyze partnership discussions
Previous Flipbook
Quarterly Report Q2 2018
Quarterly Report Q2 2018

Next Flipbook
Annual Information Form 2017
Annual Information Form 2017

Prometic Annual Information Form 2017